Position in AMGN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$4,301,985
+$850,337 QoQ
Shares Held
11,880
+21.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.70%
of 13F equity value
Holder Rank
#913
of 3,140 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026New England Research & Management, Inc. holds $31,997,185 across 8 Drug Manufacturers - General names. AMGN ranks #3 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
29,527 | $7,498,972 | |
| 2 | ABBV |
AbbVie Inc.
|
24,774 | $6,234,129 | |
| 3 | AMGN |
Amgen Inc
This page
|
11,880 | $4,301,985 | |
| 4 | LLY |
ELI LILLY & Co
|
3,556 | $4,265,173 | |
| 5 | MRK |
Merck & Co., Inc.
|
27,279 | $3,505,351 | |
| 6 | AZN |
Astrazeneca PLC
|
15,893 | $3,013,630 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
21,070 | $2,661,983 | |
| 8 | PFE |
Pfizer Inc
|
21,427 | $515,962 |
All Filings in AMGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,301,985 | 11,880 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $3,451,648 | 9,810 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,125,878 | 6,495 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,402,534 | 4,970 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $1,289,950 | 4,620 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $792,271 | 2,543 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,425,440 | 5,469 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $3,407,048 | 10,574 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $2,519,596 | 8,064 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $2,545,516 | 8,953 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,670,516 | 5,800 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,676,849 | 9,960 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $3,159,344 | 14,230 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $2,430,796 | 10,055 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $1,386,739 | 5,280 | Shares | Sole | 2023-01-09 | |
| 2022-03-31 | $643,241 | 2,660 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $620,917 | 2,760 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $658,151 | 3,095 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $1,627,031 | 6,675 | Shares | Sole | 2021-07-15 | |
| 2020-09-30 | $355,824 | 1,400 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $879,521 | 3,729 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $299,837 | 1,479 | Shares | Sole | 2020-06-15 | |
| No filing history on record for this holder in this stock. | ||||||